CN114452236A - 温泉水面膜 - Google Patents
温泉水面膜 Download PDFInfo
- Publication number
- CN114452236A CN114452236A CN202210219934.9A CN202210219934A CN114452236A CN 114452236 A CN114452236 A CN 114452236A CN 202210219934 A CN202210219934 A CN 202210219934A CN 114452236 A CN114452236 A CN 114452236A
- Authority
- CN
- China
- Prior art keywords
- mass
- parts
- extract
- spring water
- homogenizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 70
- 238000002156 mixing Methods 0.000 claims abstract description 29
- 239000000203 mixture Substances 0.000 claims abstract description 29
- 238000002360 preparation method Methods 0.000 claims abstract description 29
- 238000001816 cooling Methods 0.000 claims abstract description 27
- 238000003756 stirring Methods 0.000 claims abstract description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 24
- 241000209140 Triticum Species 0.000 claims abstract description 24
- 235000021307 Triticum Nutrition 0.000 claims abstract description 24
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 24
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 24
- 238000010438 heat treatment Methods 0.000 claims abstract description 22
- 241001474374 Blennius Species 0.000 claims abstract description 21
- 239000012528 membrane Substances 0.000 claims abstract description 21
- 239000000835 fiber Substances 0.000 claims abstract description 20
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 18
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000706 filtrate Substances 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 13
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 9
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 9
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 9
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims abstract description 9
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims abstract description 9
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 9
- 229960000458 allantoin Drugs 0.000 claims abstract description 9
- 229960003237 betaine Drugs 0.000 claims abstract description 9
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims abstract description 9
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 9
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims abstract description 9
- 229960002216 methylparaben Drugs 0.000 claims abstract description 9
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 9
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 9
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims abstract description 6
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims abstract description 6
- 229940106189 ceramide Drugs 0.000 claims abstract description 6
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims abstract description 6
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 6
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000004806 packaging method and process Methods 0.000 claims abstract description 6
- 238000005086 pumping Methods 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims abstract description 6
- 238000001514 detection method Methods 0.000 claims abstract description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 23
- 229960005323 phenoxyethanol Drugs 0.000 claims description 23
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 15
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 claims description 13
- 229960003993 chlorphenesin Drugs 0.000 claims description 13
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 10
- 241000219304 Portulacaceae Species 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 229940064064 purslane extract Drugs 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 235000002789 Panax ginseng Nutrition 0.000 claims description 5
- 239000004288 Sodium dehydroacetate Substances 0.000 claims description 5
- 241000028204 Vincetoxicum atratum Species 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 5
- 229940059958 centella asiatica extract Drugs 0.000 claims description 5
- 229940079839 sodium dehydroacetate Drugs 0.000 claims description 5
- 235000019259 sodium dehydroacetate Nutrition 0.000 claims description 5
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 claims description 5
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical compound O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 claims description 2
- 238000004945 emulsification Methods 0.000 claims description 2
- 229960002479 isosorbide Drugs 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 abstract description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 4
- -1 dimethyl isosorbide anhydride Chemical class 0.000 abstract description 4
- 235000008434 ginseng Nutrition 0.000 abstract description 4
- 230000002087 whitening effect Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 2
- 238000005303 weighing Methods 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 3
- MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 3
- 244000037364 Cinnamomum aromaticum Species 0.000 description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 3
- 229940072056 alginate Drugs 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 239000001140 aloe barbadensis leaf extract Substances 0.000 description 3
- 229940116229 borneol Drugs 0.000 description 3
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 3
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 3
- 235000015110 jellies Nutrition 0.000 description 3
- 239000008274 jelly Substances 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
本申请公开了温泉水面膜,按照质量百分比称量原料,其制备方法包括:S1:向反应釜内向加入水、甘油、甲基丙二醇、透明质酸钠、海藻胶、尿囊素、甜菜碱、羟苯甲酯、VB3、VB5,高速均质后升温至80‑85℃,并保温;S2:将1.2己二醇、白薇提取物、红参提取物、马齿苋混合提取物、Ucare UA1210、积雪草提取物、温泉水混合物加入油锅并混合均匀,升温到80‑85℃抽入反应釜,恒温80℃下进行乳化,高速均质;S3:加入决明子提取物、水解小麦蛋白提取物、异山梨醇酐二甲醚、甘草酸二钾、冰片,高速均质后中速搅拌;S4:降温至43‑47℃,加入水溶性神经酰胺中速搅拌均匀;S5:检测合格后获取滤液,冷却后浸入纤维膜,无菌密封包装。本申请的温泉水面膜,对皮肤由修复、美白效果。
Description
技术领域
本申请涉及护肤品技术领域,具体是温泉水面膜。
背景技术
面膜是利用覆盖在脸部的时间内,隔离外界的空气与污染,扩张皮肤的毛孔,促进汗腺分泌与新陈代谢,使肌肤的含氧量上升,有利于肌肤排除表皮细胞新陈代谢的产物和累积的油脂类物质,面膜中的有效成分渗入皮肤表皮的角质层,使皮肤变得柔软、光亮。目前,市场上的面膜产品种类诸多,宣传的产品功效也十分多样,但是,也存在些许产品虚假宣传功效的情况。为此,本申请提出了一种具有良好肌肤修复能力的温泉水面膜。
发明内容
本申请的目的在于提供温泉水面膜,利用添加物质的活性成分和保健因子,对皮肤进行修复、美白等,原料组分和制备方法简单。
为实现上述目的,本申请提供了温泉水面膜,按照质量百分比称量原料,其制备方法具体包括以下步骤:
S1:向反应釜内向加入81.99945%的水、5%的甘油、5%的甲基丙二醇、0.1%的透明质酸钠、0.2%的海藻胶、0.1%的尿囊素、1.2%的甜菜碱、0.15%的羟苯甲酯、0.8%的VB3、 0.2%的VB5,高速均质5-10min后升温至80-85℃,保温15-25min;
S2:将0.7%的1.2己二醇、0.5%的白薇提取物、0.05%的红参提取物、0.8%的马齿苋混合提取物、2%的Ucare UA1210、0.1%的积雪草提取物、1%的温泉水混合物依次加入油锅并混合均匀,升温到80-85℃后抽入所述反应釜内,设定乳化温度为恒温80℃下进行乳化,高速均质3-5min;
S3:向所述反应釜内加入0.2%的决明子提取物、0.2%的水解小麦蛋白提取物、0.1%的异山梨醇酐二甲醚、0.05%的甘草酸二钾、0.00015%的冰片,高速均质3-5min后中速搅拌8-12min;
S4:降温至43-47℃,向所述反应釜内加入0.1%的水溶性神经酰胺中速搅拌均匀;
S5:对溶液进行检测,检测合格后过滤获取滤液,滤液静置冷却后浸入纤维膜,杀菌后在无菌环境下密封包装。
在一种实施方式中,所述海藻胶的制备方法为:将28-32质量份的水、12-14质量份的丙二醇、4-8质量份的小叶海藻提取物、14-16质量份的苯氧乙醇、11-13质量份的氯苯甘醚、14-16质量份的脱氢乙酸钠混合后高速均质,滤液后获取所述海藻胶。
在一种实施方式中,所述马齿苋提取混合物的制备方法为:将15-20质量份的马齿苋提取物、8-12质量份的丁二醇、5-9质量份的苯氧乙醇、6-8质量份的氯苯甘醚、35-50质量份的水混合后,升温至60-90℃并高速均质,冷却后滤液获取所述马齿苋提取混合物。
在一种实施方式中,所述温泉水混合物的制备方法为:将60-80质量份的温泉水、10-15 质量份的丁二醇、5-8质量份的苯氧乙醇混合后中速搅拌均匀,煮沸5-10min,无菌环境下冷却后获取所述温泉水混合物。
在一种实施方式中,所述水解小麦蛋白提取物的制备方法为:将10-14质量份的丁二醇、30-35质量份的水解小麦蛋白、5-8质量份的苯氧乙醇、60-80质量份的水混合,升温至50-60℃后中速搅拌2-3min,冷却后获取所述水解小麦蛋白提取物。
在一种实施方式中,所述纤维膜的制备方法为:将生物纤维膜放置于35-50℃下25-30min,取出杀菌处理获取所述纤维膜。
综上所述,本申请的温泉水面膜,能够充分发挥原料中的活性成分和保健因子,使面膜具备对皮肤修复、美白的功效。原材料资源丰富,简单易得,制备方法简单。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
一种温泉水面膜,按质量百分比,包括以下原料:81.99945%的水、5%的甘油、5%的甲基丙二醇、0.1%的透明质酸钠、0.2%的海藻胶、0.1%的尿囊素、1.2%的甜菜碱、0.15%的羟苯甲酯、0.8%的VB3、0.2%的VB5、0.7%的1.2己二醇、0.5%的白薇提取物、0.05%的红参提取物、0.8%的马齿苋混合提取物、2%的Ucare UA1210、0.1%的积雪草提取物、 1%的温泉水混合物、0.2%的决明子提取物、0.2%的水解小麦蛋白提取物、0.1%的异山梨醇酐二甲醚、0.05%的甘草酸二钾、0.00015%的冰片。
在本实施例中,按照质量百分比称量原料,温泉水面膜的制备方法具体包括以下步骤:
S1:向反应釜内向加入水、甘油、甲基丙二醇、透明质酸钠、海藻胶、尿囊素、甜菜碱、羟苯甲酯、VB3、VB5,高速均质5min后升温至80℃,保温15min;
S2:将1.2己二醇、白薇提取物、红参提取物、马齿苋混合提取物、Ucare UA1210、积雪草提取物、温泉水混合物依次加入油锅并混合均匀,升温到80-85℃后抽入反应釜内,设定乳化温度为恒温80℃下进行乳化,高速均质3min;
S3:向反应釜内加入决明子提取物、水解小麦蛋白提取物、异山梨醇酐二甲醚、甘草酸二钾、冰片,高速均质3min后以800rpm的转速搅拌8min;
S4:降温至43℃,向反应釜内加入水溶性神经酰胺中速搅拌均匀;
S5:对溶液进行检测,检测合格后过滤获取滤液,滤液静置冷却后浸入纤维膜,杀菌后在无菌环境下密封包装
其中:
海藻胶的制备方法为:将28质量份的水、12质量份的丙二醇、4质量份的小叶海藻提取物、14质量份的苯氧乙醇、11质量份的氯苯甘醚、14质量份的脱氢乙酸钠混合后高速均质,滤液后获取海藻胶;
马齿苋提取混合物的制备方法为:将15质量份的马齿苋提取物、8质量份的丁二醇、 5质量份的苯氧乙醇、6质量份的氯苯甘醚、35质量份的水混合后,升温至60℃并高速均质,冷却后滤液获取马齿苋提取混合物;
温泉水混合物的制备方法为:将60质量份的温泉水、10质量份的丁二醇、5质量份的苯氧乙醇混合后中速搅拌均匀,煮沸5min,无菌环境下冷却后获取温泉水混合物;
水解小麦蛋白提取物的制备方法为:将10质量份的丁二醇、30质量份的水解小麦蛋白、5质量份的苯氧乙醇、60质量份的水混合,升温至50℃后中速搅拌2min,冷却后获取水解小麦蛋白提取物;
纤维膜的制备方法为:将生物纤维膜放置于35℃下25min,取出杀菌处理获取纤维膜;
Ucare UA1210的制备方法为:将35质量份的库拉索芦荟叶汁、12质量份的苯氧乙醇、 15质量份的氯苯甘醚混合后中速搅拌均匀,获取Ucare UA1210。
实施例2
一种温泉水面膜,按质量百分比,包括以下原料:81.99945%的水、5%的甘油、5%的甲基丙二醇、0.1%的透明质酸钠、0.2%的海藻胶、0.1%的尿囊素、1.2%的甜菜碱、0.15%的羟苯甲酯、0.8%的VB3、0.2%的VB5、0.7%的1.2己二醇、0.5%的白薇提取物、0.05%的红参提取物、0.8%的马齿苋混合提取物、2%的Ucare UA1210、0.1%的积雪草提取物、 1%的温泉水混合物、0.2%的决明子提取物、0.2%的水解小麦蛋白提取物、0.1%的异山梨醇酐二甲醚、0.05%的甘草酸二钾、0.00015%的冰片。
在本实施例中,按照质量百分比称量原料,温泉水面膜的制备方法具体包括以下步骤:
S1:向反应釜内向加入水、甘油、甲基丙二醇、透明质酸钠、海藻胶、尿囊素、甜菜碱、羟苯甲酯、VB3、VB5,高速均质8min后升温至82℃,保温20min;
S2:将1.2己二醇、白薇提取物、红参提取物、马齿苋混合提取物、Ucare UA1210、积雪草提取物、温泉水混合物依次加入油锅并混合均匀,升温到80-85℃后抽入反应釜内,设定乳化温度为恒温80℃下进行乳化,高速均质4min;
S3:向反应釜内加入决明子提取物、水解小麦蛋白提取物、异山梨醇酐二甲醚、甘草酸二钾、冰片,高速均质4min后在800rpm的转速下搅拌10min;
S4:降温至45℃,向反应釜内加入水溶性神经酰胺中速搅拌均匀;
S5:对溶液进行检测,检测合格后过滤获取滤液,滤液静置冷却后浸入纤维膜,杀菌后在无菌环境下密封包装
其中:
海藻胶的制备方法为:将30质量份的水、13质量份的丙二醇、6质量份的小叶海藻提取物、15质量份的苯氧乙醇、12质量份的氯苯甘醚、15质量份的脱氢乙酸钠混合后高速均质,滤液后获取海藻胶;
马齿苋提取混合物的制备方法为:将18质量份的马齿苋提取物、10质量份的丁二醇、 7质量份的苯氧乙醇、7质量份的氯苯甘醚、42质量份的水混合后,升温至75℃并高速均质,冷却后滤液获取马齿苋提取混合物;
温泉水混合物的制备方法为:将70质量份的温泉水、12质量份的丁二醇、6质量份的苯氧乙醇混合后中速搅拌均匀,煮沸8min,无菌环境下冷却后获取温泉水混合物;
水解小麦蛋白提取物的制备方法为:将12质量份的丁二醇、32质量份的水解小麦蛋白、7质量份的苯氧乙醇、70质量份的水混合,升温至55℃后中速搅拌2min,冷却后获取水解小麦蛋白提取物;
纤维膜的制备方法为:将生物纤维膜放置于42℃下27min,取出杀菌处理获取纤维膜;
Ucare UA1210的制备方法为:将38质量份的库拉索芦荟叶汁、13质量份的苯氧乙醇、 16质量份的氯苯甘醚混合后中速搅拌均匀,获取Ucare UA1210。
实施例3
一种温泉水面膜,按质量百分比,包括以下原料:81.99945%的水、5%的甘油、5%的甲基丙二醇、0.1%的透明质酸钠、0.2%的海藻胶、0.1%的尿囊素、1.2%的甜菜碱、0.15%的羟苯甲酯、0.8%的VB3、0.2%的VB5、0.7%的1.2己二醇、0.5%的白薇提取物、0.05%的红参提取物、0.8%的马齿苋混合提取物、2%的Ucare UA1210、0.1%的积雪草提取物、 1%的温泉水混合物、0.2%的决明子提取物、0.2%的水解小麦蛋白提取物、0.1%的异山梨醇酐二甲醚、0.05%的甘草酸二钾、0.00015%的冰片。
在本实施例中,按照质量百分比称量原料,温泉水面膜的制备方法具体包括以下步骤:
S1:向反应釜内向加入水、甘油、甲基丙二醇、透明质酸钠、海藻胶、尿囊素、甜菜碱、羟苯甲酯、VB3、VB5,高速均质10min后升温至85℃,保温25min;
S2:将1.2己二醇、白薇提取物、红参提取物、马齿苋混合提取物、Ucare UA1210、积雪草提取物、温泉水混合物依次加入油锅并混合均匀,升温到85℃后抽入反应釜内,设定乳化温度为恒温80℃下进行乳化,高速均质5min;
S3:向反应釜内加入决明子提取物、水解小麦蛋白提取物、异山梨醇酐二甲醚、甘草酸二钾、冰片,高速均质5min后中速搅拌12min;
S4:降温至47℃,向反应釜内加入水溶性神经酰胺中速搅拌均匀;
S5:对溶液进行检测,检测合格后过滤获取滤液,滤液静置冷却后浸入纤维膜,杀菌后在无菌环境下密封包装
其中:
海藻胶的制备方法为:将32质量份的水、14质量份的丙二醇、8质量份的小叶海藻提取物、16质量份的苯氧乙醇、13质量份的氯苯甘醚、16质量份的脱氢乙酸钠混合后高速均质,滤液后获取海藻胶;
马齿苋提取混合物的制备方法为:将20质量份的马齿苋提取物、12质量份的丁二醇、 9质量份的苯氧乙醇、8质量份的氯苯甘醚、50质量份的水混合后,升温至90℃并高速均质,冷却后滤液获取马齿苋提取混合物;
温泉水混合物的制备方法为:将80质量份的温泉水、15质量份的丁二醇、8质量份的苯氧乙醇混合后中速搅拌均匀,煮沸10min,无菌环境下冷却后获取温泉水混合物;
水解小麦蛋白提取物的制备方法为:将14质量份的丁二醇、35质量份的水解小麦蛋白、8质量份的苯氧乙醇、80质量份的水混合,升温至60℃后中速搅拌3min,冷却后获取水解小麦蛋白提取物;
纤维膜的制备方法为:将生物纤维膜放置于50℃下30min,取出杀菌处理获取纤维膜;
Ucare UA1210的制备方法为:将42质量份的库拉索芦荟叶汁、14质量份的苯氧乙醇、 18质量份的氯苯甘醚混合后中速搅拌均匀,获取Ucare UA1210。
表1为对实施例1、实施例2、实施例3根据化妆品安全技术规范进行的产品检测部分结果:
表1
最后应说明的是:以上仅所述为本发明的优选实施例而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (6)
1.温泉水面膜,其特征在于,按照质量百分比称量原料,其制备方法具体包括以下步骤:
S1:向反应釜内向加入81.99945%的水、5%的甘油、5%的甲基丙二醇、0.1%的透明质酸钠、0.2%的海藻胶、0.1%的尿囊素、1.2%的甜菜碱、0.15%的羟苯甲酯、0.8%的VB3、0.2%的VB5,高速均质5-10min后升温至80-85℃,保温15-25min;
S2:将0.7%的1.2己二醇、0.5%的白薇提取物、0.05%的红参提取物、0.8%的马齿苋混合提取物、2%的Ucare UA1210、0.1%的积雪草提取物、1%的温泉水混合物依次加入油锅并混合均匀,升温到80-85℃后抽入所述反应釜内,设定乳化温度为恒温80℃下进行乳化,高速均质3-5min;
S3:向所述反应釜内加入0.2%的决明子提取物、0.2%的水解小麦蛋白提取物、0.1%的异山梨醇酐二甲醚、0.05%的甘草酸二钾、0.00015%的冰片,高速均质3-5min后中速搅拌8-12min;
S4:降温至43-47℃,向所述反应釜内加入0.1%的水溶性神经酰胺中速搅拌均匀;
S5:对溶液进行检测,检测合格后过滤获取滤液,滤液静置冷却后浸入纤维膜,杀菌后在无菌环境下密封包装。
2.根据权利要求1所述的温泉水面膜,其特征在于,所述海藻胶的制备方法为:将28-32质量份的水、12-14质量份的丙二醇、4-8质量份的小叶海藻提取物、14-16质量份的苯氧乙醇、11-13质量份的氯苯甘醚、14-16质量份的脱氢乙酸钠混合后高速均质,滤液后获取所述海藻胶。
3.根据权利要求1所述的温泉水面膜,其特征在于,所述马齿苋提取混合物的制备方法为:将15-20质量份的马齿苋提取物、8-12质量份的丁二醇、5-9质量份的苯氧乙醇、6-8质量份的氯苯甘醚、35-50质量份的水混合后,升温至60-90℃并高速均质,冷却后滤液获取所述马齿苋提取混合物。
4.根据权利要求1所述的温泉水面膜,其特征在于,所述温泉水混合物的制备方法为:将60-80质量份的温泉水、10-15质量份的丁二醇、5-8质量份的苯氧乙醇混合后中速搅拌均匀,煮沸5-10min,无菌环境下冷却后获取所述温泉水混合物。
5.根据权利要求1所述的温泉水面膜,其特征在于,所述水解小麦蛋白提取物的制备方法为:将10-14质量份的丁二醇、30-35质量份的水解小麦蛋白、5-8质量份的苯氧乙醇、60-80质量份的水混合,升温至50-60℃后中速搅拌2-3min,冷却后获取所述水解小麦蛋白提取物。
6.根据权利要求1所述的温泉水面膜,其特征在于,所述纤维膜的制备方法为:将生物纤维膜放置于35-50℃下25-30min,取出杀菌处理获取所述纤维膜。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210219934.9A CN114452236A (zh) | 2022-03-08 | 2022-03-08 | 温泉水面膜 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210219934.9A CN114452236A (zh) | 2022-03-08 | 2022-03-08 | 温泉水面膜 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114452236A true CN114452236A (zh) | 2022-05-10 |
Family
ID=81417141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210219934.9A Pending CN114452236A (zh) | 2022-03-08 | 2022-03-08 | 温泉水面膜 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114452236A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110237006A (zh) * | 2019-07-25 | 2019-09-17 | 深圳依云四季文化旅游发展有限公司 | 护肤组合物及面膜 |
CN111588679A (zh) * | 2020-04-01 | 2020-08-28 | 爱乐星丽化妆品制造(上海)有限公司 | 一种保湿护肤面膜及其制备工艺 |
CN113893186A (zh) * | 2021-09-16 | 2022-01-07 | 广州佳成生物科技有限公司 | 多效时光修护精华液 |
-
2022
- 2022-03-08 CN CN202210219934.9A patent/CN114452236A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110237006A (zh) * | 2019-07-25 | 2019-09-17 | 深圳依云四季文化旅游发展有限公司 | 护肤组合物及面膜 |
CN111588679A (zh) * | 2020-04-01 | 2020-08-28 | 爱乐星丽化妆品制造(上海)有限公司 | 一种保湿护肤面膜及其制备工艺 |
CN113893186A (zh) * | 2021-09-16 | 2022-01-07 | 广州佳成生物科技有限公司 | 多效时光修护精华液 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104257519A (zh) | 菠萝叶纳米纤维素保湿美白水洗凝胶面膜及制备方法 | |
CN106473983A (zh) | 一种保湿精华液及其制备方法 | |
CN104887563B (zh) | 一种雪菊茶防敏面膜霜及其制备方法 | |
CN107184522A (zh) | 一种皮肤抗敏修复乳液及其制备方法 | |
CN106726653A (zh) | 一种拯救激素脸的修复面膜组合物及其制备方法 | |
CN108165583A (zh) | 枸杞酶解发酵液及制备工艺及在化妆品中的应用 | |
CN106361675A (zh) | 一种中草药护肤品的制备方法 | |
CN112538405A (zh) | 一种纯粮黄精米酒及其酿造方法 | |
CN111773161A (zh) | 一种益生元组合物及其制备方法和应用 | |
CN114452236A (zh) | 温泉水面膜 | |
CN107982143A (zh) | 菟丝子发酵液及制备工艺及在化妆品中的应用 | |
CN106420565A (zh) | 一种中草药面膜的制备方法 | |
CN103655439A (zh) | 一种生物发酵护肤水及其制备方法 | |
CN111419766B (zh) | 一种使用薏仁水的保湿乳液及其制备方法 | |
CN107348063A (zh) | 一种保健葛根茶的制备方法 | |
CN111529468A (zh) | 一种补水保湿的面膜精华液及其制备方法 | |
CN109044870A (zh) | 一种美肌滋养冰膜及其制备方法 | |
CN110882196A (zh) | 舒缓活力霜及其制备方法 | |
CN105985873A (zh) | 一种松果和金樱子黄酒及其酿造方法 | |
CN113893186A (zh) | 多效时光修护精华液 | |
CN115192700A (zh) | 一种抑制hpv病毒的生物蛋白肽制剂 | |
CN108403558A (zh) | 一种铁皮石斛面膜产品 | |
CN107951809B (zh) | 一种含有甘蔗提取物的美白修护精华液及其制备方法 | |
CN103349691A (zh) | 一种用于消炎止血的发酵液体的制备方法 | |
CN105708766A (zh) | 一种利用海藻提取液制备水溶性海藻面膜的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220510 |